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Background. Since the introduction of the Haemophilus influenzae serotype b vaccine, H influenzae epidemi-
ology has shifted. In the United States, the largest burden of disease is now in adults aged ≥65 years. However, few
data exist on risk factors for disease severity and outcome in this age group.
Methods. A retrospective case-series review of invasive H influenzae infections in patients aged ≥65 years was
conducted for hospitalized cases reported to Active Bacterial Core surveillance in 2011.
Results. There were 299 hospitalized cases included in the analysis. The majority of cases were caused by non-
typeable H influenzae, and the overall case fatality ratio (CFR) was 19.5%. Three or more underlying conditions were
present in 63% of cases; 94% of cases had at least 1. Patients with chronic heart conditions (congestive heart failure,
coronary artery disease, and/or atrial fibrillation) (odds ratio [OR], 3.27; 95% confidence interval [CI], 1.65–6.46),
patients from private residences (OR, 8.75; 95% CI, 2.13–35.95), and patients who were not resuscitate status (OR,
2.72; 95% CI, 1.31–5.66) were more likely to be admitted to the intensive care unit (ICU). Intensive care unit ad-
mission (OR, 3.75; 95% CI, 1.71–8.22) and do not resuscitate status (OR, 12.94; 95% CI, 4.84–34.55) were signifi-
cantly associated with death.
Conclusions. Within this age group, burden of disease and CFR both increased significantly as age increased.
Using ICU admission as a proxy for disease severity, our findings suggest several conditions increased risk of disease
severity and patients with severe disease were more likely to die. Further research is needed to determine the most
effective approach to prevent H influenzae disease and mortality in older adults.
Keywords. Haemophilus influenzae; older adults.
Since the introduction of the Haemophilus influenzae
serotype b (Hib) vaccine, H influenzae epidemiology
in the United States has shifted; nontypeable H influen-
zae has emerged as the cause of most invasive disease
in all age groups [1]. In the United States, adults aged
≥65 years now account for the largest proportion of
H influenzae disease, and the risk of disease increases
with increasing age [1–3]. The case fatality ratio (CFR)
is also highest in this older age group [1, 2].
Few studies have focused on invasive H influenzae in
persons ≥65 years, and as a result there is limited infor-
mation available on risk factors for disease in this age
group [1, 3]. A previous study using Active Bacterial
Core surveillance (ABCs) data from 1999 to 2008 de-
scribed the characteristics of patients with invasive
H influenzae and assessed risk factors for in-hospital
mortality, but it did not focus on older adults [3]. We
conducted a case-series review of hospitalized invasive
H influenzae cases ≥65 years identified through an ac-
tive, population- and laboratory-based surveillance sys-
tem in the United States to further examine the burden
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of disease, possible risk factors, and the potential impact of un-
derlying conditions on disease severity and outcome.
METHODS
A retrospective case-series review of invasive H influenzae
infections in patients aged ≥65 years was conducted for hospi-
talized cases reported to ABCs in 2011. Active Bacterial Core
surveillance is an active, population- and laboratory-based sur-
veillance system that includes all or part of the following 10
states: California, Colorado, Connecticut, Georgia, Maryland,
Minnesota, New Mexico, New York, Oregon, and Tennessee
[4]. Active Bacterial Core surveillance is supported by the Cen-
ters for Disease Control and Prevention (CDC) as part of its
Emerging Infections Program Network [5]. The population
under surveillance was 42 421 940 in 2011 (representing
13.6% of the US population), and the population aged ≥65
years under surveillance was 5 326 646.
A case was defined as isolation of H influenzae from a nor-
mally sterile site (eg, blood or cerebrospinal fluid [CSF]) in a
resident of a surveillance area. The standard ABCs case report
form collects demographics, clinical syndrome, underlying con-
ditions, serotype, and outcome data abstracted from medical re-
cords. Outcome of illness was based on patient status at the time
of hospital discharge; no information was collected on whether
the death was attributed to H influenzae infection.
The clinical syndrome was defined as meningitis if a clinical
diagnosis of meningitis was reported in the medical record or if
H influenzae was isolated from the CSF. The syndrome was de-
fined as pneumonia if pneumonia was reported in the medical
record and H influenzae was isolated from blood or pleural
fluid. If no clinical syndrome was listed in the medical record
and H influenzae was isolated from blood, then the syndrome
was defined as bacteremia.
Available isolates for all H influenzae cases were sent to the
CDC for confirmation by Haemophilus quad identification
plates, API Neisseria-Haemophilus strips, and polymerase
chain reaction (PCR) [6–8]. Haemophilus influenzae serotype
was determined by slide agglutination or serotype-specific
real-time PCR assays.
An expanded case report form was used to collect additional
information from the medical record on hospitalized cases: res-
idence location at time of initial culture; other underlying con-
ditions not collected by the ABCs case report form including
cognitive dysfunction, recent upper or lower respiratory tract
infections, active or inactive tuberculosis, and atrial fibrillation;
symptoms and physical examination findings at admission; in-
formation on any recent surgeries, tests, procedures, and inter-
ventions conducted during hospital stay (chest x-ray or chest
computed tomography [CT], mechanical ventilation, respirato-
ry support, do not resuscitate [DNR] status, antibiotic use, sub-
sequent positive cultures, and culture confirmation of other
invasive illnesses); intensive care unit (ICU) admission and du-
ration of stay; diagnoses and ICD-9/10 codes at discharge; and
discharge location.
Estimates of the prevalence of coronary artery disease (CAD),
congestive heart failure (CHF), and current smoking among adults
≥65 years were obtained from the 2009–2010 National Health and
Nutrition Examination Survey (NHANES) for comparison to the
prevalence among cases of H influenzae [9]. NHANES uses a na-
tionally representative sample and oversamples the population
≥60 years to ensure reliable statistics. The sample does not include
persons living in nursing homes or other institutions. The preva-
lence of chronic obstructive pulmonary disease (COPD), atrial fi-
brillation, diabetes, dementia, and hypertension in adults ≥65
years was obtained from the literature [10–14].
Estimated average annual incidence rates of invasive H influ-
enzae infections in adults ≥65 years were calculated for the
United States using 2009 through 2011 census data and are
reported per 100 000 population. For incidence calculations
only, ABCs case reports from 2009 through 2011 were used.
A multiyear range was used to obtain more accurate incidence
estimates due to small case counts in the individual years. For
national incidence estimates, race- and age-specific rates of disease
were applied from the aggregate ABCs areas to the race- and age-
specific distribution of the US population.
Statistical Analyses
SAS version 9.3 was used for all analyses (SAS Institute, Inc,
Cary, NC). Associations were evaluated using the χ2 test, and
the Student’s t test was used to compare means of continuous
variables by outcome and severity of disease. Age was divided
into 5 categories (65–69 years, 70–74 years, 75–79 years, 80–84
years, and ≥85 years), and trends across these age groups were
assessed using the Cochran-Armitage test for trend. Multivari-
able analysis was performed using logistic regression to deter-
mine associations with death or ICU admission.
The study protocol was exempted from review by the CDC,
Maryland Department of Health and Mental Hygiene, and
Johns Hopkins Institutional Review Boards and was approved
by the Georgia Department of Public Health, Emory University,
and the Department of Veterans Affairs Institutional Review
Boards. No other sites required institutional review board review.
RESULTS
During 2009 through 2011, the estimated average annual inci-
dence of invasive H influenzae infections in the United States
was 6.50 per 100 000 population in persons aged ≥65 years. In-
cidence was highest for nontypeable H influenzae (5.05 per
100 000 population) and increased with age (Table 1).
Three hundred fifteen cases of invasive H influenzae infec-
tions in patients aged ≥65 years were reported from participat-
ing ABCs sites in 2011. Of these, 299 (95%) were hospitalized
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and had a chart available for review; the following results will
focus on these 299 cases. Cases had a median age of 79 years
(range, 65–103 years) and a median body mass index in the
overweight category (median, 26.0; range, 15.8–57.0). Males ac-
counted for 44% of cases. Most cases were white (83%), non-
Hispanic (64%), and living in a private residence (74%) or
long-term care facility (19%) at the time of illness onset. Bac-
teremic pneumonia was the most common clinical syndrome
(81%), followed by bacteremia (13%) and meningitis (4%).
Thirty cases did not have serotype information available.
Among cases with available serotype information, the majority
of cases in all age groups were caused by nontypeable H influ-
enzae (78%), and the proportion of cases caused by nontypeable
H influenzae increased with increasing age (Table 2). Serotypes
f (12%), e (6%), and a (2%) were all more frequent than serotype
b (1%). The highest proportion of both serotype e and f disease
was seen in persons aged 65–69 years (Table 2). Fifty-eight
(19%) case-patients died. The overall CFR was 19.5% and in-
creased with age, ranging from 10.2% to 27.5% (Table 2);
CFR did not differ significantly by serotype or syndrome.
At least 1 underlying condition was present in 94% of cases,
with 1 underlying condition in 12% of cases, 2 in 19% of cases,
and 3 or more in 63% of cases. The most frequently reported
underlying conditions were COPD, CAD, CHF, atrial fibrilla-
tion, diabetes, hypertension, dementia, and smoking (Table 3).
Chronic obstructive pulmonary disease, CAD, CHF, atrial fibril-
lation, diabetes, and dementia were all more common in cases
than in the general population ≥65 years, whereas hypertension
and smoking were less common in cases than the general popu-
lation [9–14] (Table 3). P values were not calculated for COPD,
atrial fibrillation, diabetes, hypertension, or dementia because
only percentages were available in the literature. Thirteen percent
of cases had been hospitalized in the 60 days before illness onset,
and 4% of cases had surgery in the 30 days before illness onset.
Ninety-seven percent of cases had a chest x-ray or chest CT
performed within 24 hours of admission. A consolidation or in-
filtrate was found in 76% of these cases and was reported as a
new finding in 84%. Ninety-five percent of cases received anti-
biotics for at least 3 days, and 60% received more than 1 antibi-
otic. Seven percent of cases had a subsequent culture positive for
H influenzae, and 6% of cases had another invasive bacterial in-
fection during hospitalization. One hundred thirty-one cases
(44%) were admitted to the ICU; of these, 25% spent more
than 1 week in the ICU. Two hundred four cases (68%) required
some form of respiratory support, and 59 cases (20%) required
mechanical ventilation during hospitalization. Of those requir-
ing mechanical ventilation, 97% were admitted to the ICU.
Forty-nine (85%) of the cases that died were DNR status
upon admission.
Based on multivariable analysis using backward selection,
patients with chronic heart conditions (CHF, CAD, or atrial fi-
brillation), patients from private residences, and patients who
were DNR status were more likely to be admitted to the ICU
(OR, 3.27; 95% CI, 1.65–6.46; OR, 8.75; 95% CI, 2.13–35.95;
and OR, 2.72; 95% CI, 1.31–5.66, respectively). In univariable
analyses looking at mortality, cases that died were older
Table 1. Annual Estimated Incidence (per 100 000) of Haemophilus
influenzae in Persons Aged ≥65 Years, by Age Group and
Serotype, United States, 2009–2011
Serotype
Total†Age, Years b Non-b Nontypeable
65–69 0.12 1.19 2.29 3.60
70–74 0.04 1.26 3.74 5.04
75–79 0.05 1.53 4.43 6.01
80–84 0.14 1.33 6.32 7.78
≥85 0 1.80 13.05 14.85
Overall 0.08 1.37 5.05 6.50
† Cochran-Armitage test for trend: P < .0001.
Table 2. Serotype and Case Fatality Ratio by Age Group for Hospitalized Cases of Haemophilus influenzae aged ≥65 years, Active Bac-
terial Core Surveillance, 2011
Serotype* no. (%)
Case Fatality Ratio‡Age, Years a b e f Nontypeable†
65–69 0 2 (3.5) 8 (14.0) 14 (24.6) 33 (57.9) 10.2
70–74 3 (7.0) 0 1 (2.3) 7 (16.3) 32 (74.4) 14.3
75–79 2 (5.3) 0 2 (5.3) 4 (10.5) 30 (79.0) 17.4
80–84 0 1 (2.6) 2 (5.1) 2 (5.1) 34 (87.2) 20.9
≥85 1 (1.1) 0 3 (3.3) 6 (6.5) 82 (89.1) 27.5
Overall 6 (2.2) 3 (1.1) 16 (6.0) 33 (12.3) 211 (78.4) 19.4
* Thirty cases were excluded due to missing serotype information.
† Cochran-Armitage test for trend: P < .0001.
‡ Cochran-Armitage test for trend: P = .0039.
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(P = .0050), more likely to live in a long-term care facility than a
private residence (P = .0002), more likely to present with short-
ness of breath (P = .0263), more likely to have been admitted to
the ICU (P = .0001), and more likely to be DNR status
(P < .0001). In a multivariable analysis using backward selec-
tion, only ICU admission (OR, 3.75; 95% CI, 1.71–8.22) and
DNR status (OR, 12.94; 95% CI, 4.84–34.55) were significantly
associated with death. All results were similar when nontype-
able H influenzae were analyzed alone.
CONCLUSIONS
This is the first review of factors related to H influenzae disease
and outcome focused on adults ≥65 years using multistate, pop-
ulation-based surveillance data. This study confirms previous
reports in the post-Hib vaccine era of the relatively high burden
of invasive H influenzae disease in adults ≥65 years, especially
pneumonia caused by nontypeable H influenzae [1–2, 15–19].
Within this older age group, incidence and the CFR both in-
creased significantly as age increased. Although nontypeable
H influenzae causes most invasive disease in adults ≥65 years,
we also found that disease caused by serotypes f and e was more
prevalent than serotype b disease, which is consistent with pre-
vious studies on non-b disease in older adults [2, 19, 20].
The most common underlying conditions found in this re-
view were consistent with previous findings from ABCs sites
[3]. However, they differed from underlying conditions identi-
fied in other studies of H influenzae infections among all adults
(cancer, immunosuppressive conditions, and alcohol abuse)
conducted outside of ABCs [15–19]. Chronic obstructive pul-
monary disease, CAD, CHF, atrial fibrillation, and diabetes
were the most common underlying conditions in our study,
each reported by over 25% of cases, and they were more com-
mon than in the general population aged ≥65 years. Chronic
obstructive pulmonary disease and diabetes have been reported
as underlying conditions in other studies of person aged ≥18
years but in lower proportions than we observed [15, 18, 19].
Coronary artery disease, CHF, and atrial fibrillation are not
commonly reported underlying conditions associated with H
influenzae disease in persons aged ≥18 years [15, 16, 18, 19].
However, in 1 small study of H influenzae cases in the elderly,
similar proportions of COPD and atrial fibrillation and higher
proportions of CAD were seen [17]. It is unclear whether these
underlying conditions increased risk for invasive disease or are
just coexisting conditions.
Using ICU admission as an indicator of disease severity, pa-
tients with severe disease were more likely to die, but none of the
underlying conditions evaluated in this study were found to be
associated with death. Other underlying conditions not listed
on the chart review form or not available in the chart could po-
tentially be associated with death, but further assessment would
be needed. Our data also suggest that patients with chronic
heart conditions or DNR status and those living in private res-
idences had more severe H influenzae disease. However, it is
also possible that patients with chronic heart conditions were
admitted to the ICU because of their underlying heart condition
and not as a result of more severe H influenzae disease. Patients
from private residences may wait longer to seek medical care
than those patients from long-term care facilities and as a result
present with more severe disease on admission.
The majority of cases in our study were living in a private res-
idence at the time of illness onset, and thus likely acquired the
disease in the community. It is difficult to identify the source of
community-acquired infection; in susceptible older adults, pha-
ryngeal colonization or invasive upper respiratory infections
may progress to invasive disease. Although asymptomatic naso-
pharyngeal colonization with H influenzae does occur, the rela-
tionship between carriage and disease development is not well
understood. Few data exist on carriage of typeable H influenzae
in adults, but several studies suggest overall H influenzae car-
riage may be as high as 42% [21–23]. Because typeable H influ-
enzae is one of the leading causes of invasive upper respiratory
infections, including otitis media, conjunctivitis, and sinusitis
[24, 25], older adults living with or caring for young children
may have increased exposure to typeable H influenzae.
This study highlights the burden of invasive H influenzae in
older adults, with incidence increasing with age. A better under-
standing of the source of invasive H influenzae, such as from
invasive upper respiratory infection or nasopharyngeal coloniza-
tion, would aid in determining appropriate prevention strategies.
Among older adults, prevention strategies such as vaccination
have many challenges, including an overall low disease burden,
reduced immunogenicity, and barriers to attaining high coverage.
Table 3. Prevalence of Common Underlying Conditions in
Hospitalized Haemophilus influenzae Cases Reported to ABCs in
2011 and the General Population Aged ≥65
H influenzae
Cases
≥65 Years
General
Population
≥65 Years* P Value†
Underlying Condition
COPD 36.0% 7.2%–11.2%
CAD 34.6% 11.4% < .0001
CHF 32.8% 7.2% <.0001
Atrial Fibrillation 29.2% 3.8%–9.0%
Diabetes 28.4% 20.1%–20.7%
Hypertension 17.1% 67%
Dementia 15.0% 6%–10%
Smoking 12.1% 18.4% .0074
Abbreviations: CAD,coronary artery disease; CHF, congestive heart failure;
COPD, chronic obstructive pulmonary disease.
* [9–14].
† Test for significant difference between the 2 proportions, P values calculated
where possible.
4 • OFID • Blain et al
Increased early recognition of H influenzae in older adults may
reduce the severity of illness in cases, but the diagnosis can be
challenging in persons with multiple comorbidities. Further re-
search is needed to determine the most effective approach to pre-
vent H influenzae disease and mortality in older adults.
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